Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. - Wikidata - wikimedia - TriplyDB

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

http://www.wikidata.org/entity/Q36338003

about

NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ Understanding and treating triple-negative breast cancer African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study Risk factors for triple-negative breast cancer in women under the age of 45 years Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes Approach to the Triple Negative Breast Cancer in New Drugs Area A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer Biomarkers in triple negative breast cancer: A review Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients A Quantitative Perspective on Surface Marker Selection for the Isolation of Functional Tumor Cells Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Epithelial-mesenchymal plasticity in carcinoma metastasis SLUG: Critical regulator of epithelial cell identity in breast development and cancer Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity The clinical and functional significance of c-Met in breast cancer: a review The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family Distinct effects of EGFR ligands on human mammary epithelial cell differentiation MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1 Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.Live multicellular tumor spheroid models for high-content imaging and screening in cancer drug discovery.Application of visualization tools to the analysis of histopathological data enhances biological insight and interpretation.Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset.The molecular portraits of breast tumors are conserved across microarray platforms.Nectin-4 is a new histological and serological tumor associated marker for breast cancer.Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin Molecular characterization of human breast tumor vascular cells.The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.A compact VEGF signature associated with distant metastases and poor outcomes.Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

P2860

Q21560948-CB3E088A-1EEA-4FC4-8A8D-04D63B72BDB5 Q22000769-9D04E9A2-7EAD-4101-9B4C-392B1988F7CE Q24620957-BCE9F136-CD95-481B-B2C5-3E1A0C654964 Q24632274-DF9F19D8-7639-4B5E-9611-879EC1C4143D Q24644075-B842BC2A-C8E7-4633-890C-5F5ABC33C9E0 Q24674085-4AE4FDC3-5D27-4944-A3E3-E544C447F697 Q26743510-0E16FDE8-856D-4AC0-B75E-47B56137BA0C Q26744054-2A69D6D8-0D8A-4E53-A9CF-AFBDF2FC33E3 Q26752846-289D1489-7BE0-4642-8E9F-4AF0EFA5D47D Q26775094-608705A7-D273-4F18-8AA4-88B522CF7ABF Q26796590-5A68BC80-7D73-4B10-A5A3-0147BB1D0F34 Q26797232-3DEDBF97-EAFD-4402-905A-60546F3233E0 Q26799987-1D7AC80E-8858-4FBC-BC70-10130CA7A9BC Q26822406-98CD2660-AD6D-4EAA-A5A9-FD29A6678384 Q26859804-0B521352-A019-4146-81D3-52F925625EFF Q26865846-9585572D-F641-49F0-B45E-32CC8CC90FB8 Q27345210-BFA70092-9BF7-451E-8A3F-6764A5411E4E Q28081415-F37AE6DC-87BC-4706-B67E-62BD7FD7DC1B Q28118941-564A44E2-3847-4C5A-99E0-58B78709F619 Q28258227-82813DA1-2931-4997-A8CE-287526C50160 Q28534115-93F0A2D1-A320-405D-8A2D-C880DB5F7518 Q28554012-3B4FA376-E00D-4D1D-84A1-3142554AA930 Q28729209-F534934F-BD88-4B98-9D52-D3F352DDCF8A Q29615393-9606EA74-D8A9-455B-9696-A574D6A6ADE4 Q30245184-9B9C78F0-8ADF-4CD5-A02A-2F4D80ECA704 Q30417120-19D0AAF5-CD3E-47F1-B747-22423D248715 Q30447049-EF3A3F64-C903-40C0-B296-C439E50C1E2B Q30491493-95D4685A-1884-4C26-A51E-F221A69A67C6 Q30573300-166483B6-86D0-4F82-84CA-275AE2EE39BD Q31086776-BB4D312C-02A3-4C04-8935-957AB92F92B5 Q31153510-DF065454-2412-447F-8715-30DECF618FE2 Q33241398-D3ABAC7F-6717-4CAF-BCC5-9D3E2EC98EA2 Q33283461-7912A850-7D47-4B65-A53B-B415D26996E3 Q33317058-79EC6E21-2C97-4E31-B0EB-8C84D749F58F Q33327647-5FF2AB33-67E3-475A-86CC-D203FF6C153B Q33371124-F84E4FBE-A5F3-4570-BCE6-8685D657DC73 Q33378965-09FCD53B-DF43-43F5-AB6E-056567BF756B Q33418745-501956C4-4BCD-4C2D-951D-1D23B79F8739 Q33434092-AB0DAAF1-5956-48F2-804A-72944928BBF8 Q33479152-74272C3B-7695-4180-A0C8-9F95444B71DE

P2860

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

http://www.wikidata.org/entity/Q36338003

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@ast

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@en

type

label

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@ast

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@en

prefLabel

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@ast

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@en

P1433

Q36338003-3A0617C3-D25B-4B86-8442-A5543F04D803

P1476

Q36338003-4E750984-F872-4B30-AABA-DFB21A924647

P2093

Q36338003-259D710A-80E5-4F22-BEB7-5D0BEF250A34

Q36338003-44845249-8D5B-4EAB-A30B-BFAD2EE6AE4C

Q36338003-4DBF1868-E3F6-4B55-B57C-CDD5C3B47F8E

Q36338003-4F16D769-80E7-4FAE-91B9-13C45593A3CF

Q36338003-7E92F78C-C45B-48AB-949E-C49FAD3BC30A

P2860

Q36338003-1F181F6A-9478-42FD-B43C-48A4091D5A33

Q36338003-2157C6D9-70BA-4526-AAAC-19FE4E140DA6

Q36338003-232F05D6-08B7-4EBD-8ECF-43E6CCECBA35

Q36338003-2E129512-201A-4F4D-B939-A0DB3C5C7CB0

Q36338003-31A2FA72-D231-4F26-824A-3F0785E6DBBD

Q36338003-3BFC7B39-9C0C-4B1E-BB1E-58A9B175989D

Q36338003-44313699-932D-4E50-9674-9DFFED9D31B2

Q36338003-5C3B8B01-4611-43CE-BCB0-2F003F2BC705

Q36338003-64E73FBB-C8F6-4B17-A035-AC0ABAEF5671

Q36338003-66B914DC-56F1-44A5-B20F-AB247C603AB9

P2888

Q36338003-46C65F38-86F6-434C-980A-0396C8A64A7E

P304

Q36338003-162BEC52-CD78-4340-B05A-DEE3EE31D5CC

P31

Q36338003-B647F627-A86C-42EC-9589-7AA3E9630BC8

P356

Q36338003-6FF615E0-D75F-4EF3-8300-E420DD1A2DB2

P433

Q36338003-DA85FC5E-884E-4BC1-B727-5D53430244D3

P478

Q36338003-3E5FDA7C-FE08-4289-9701-D00CE226C4C5

P50

Q36338003-BF9E2290-44B6-4626-97F0-88CB36659012

Q36338003-C790709A-52B8-4693-9895-FD915ED9870C

P577

Q36338003-31698F4A-9560-4E82-8A1D-D48D831A0DEF

P5875

Q36338003-5454C1BB-A617-4D39-893D-D8EA813AC47F

P6179

Q36338003-CC4EC38A-78B8-4C9A-8FD3-26395DBAC7BA

P698

Q36338003-DE99361C-4EB1-462B-BBEA-4E75C4503ECC

P356

MODPATHOL.3800528

P1433

Modern Pathology

P1476

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

@en

P2093

Chad A Livasy

http://www.w3.org/2001/XMLSchema#string

Dominic T Moore

http://www.w3.org/2001/XMLSchema#string

Gamze Karaca

http://www.w3.org/2001/XMLSchema#string

Maria S Tretiakova

http://www.w3.org/2001/XMLSchema#string

Rita Nanda

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Molecular portraits and the family tree of cancer.

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

P2888

modpathol.3800528

P304

264-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3800528

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

Olufunmilayo Olopade

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7429007

http://www.w3.org/2001/XMLSchema#string

P6179

1018899345

http://www.w3.org/2001/XMLSchema#string

P698

16341146

http://www.w3.org/2001/XMLSchema#string